Results 301 to 310 of about 73,410 (327)

Risk factors and disease mechanisms in myositis

Nature Reviews Rheumatology, 2018
Frederick W Miller, Janine A Lamb, Jens Schmidt   +2 more
exaly  

Update on outcome assessment in myositis

Nature Reviews Rheumatology, 2018
Lisa G Rider, Rohit Aggarwal, Jean-Yves Hogrel   +2 more
exaly  

Treatment in myositis

Nature Reviews Rheumatology, 2018
Rohit Aggarwal
exaly  

A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy

Clinical Reviews in Allergy and Immunology, 2015
Minoru Satoh, Angela Ceribelli, S John Calise   +2 more
exaly  

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Journal of Autoimmunity, 2019
Gavin Shaddick, Hector Chinoy, Jiri Vencovsky   +2 more
exaly  

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

Lancet Neurology, The, 2019
Olivier Benveniste, Thomas E Lloyd, Merrilee Needham, Mbbs, Fracp   +2 more
exaly  

Long-term observational study of sporadic inclusion body myositis

Brain, 2011
Olivier Benveniste, Tanya Stojkovic, Yves Allenbach   +2 more
exaly  

The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome

Autoimmunity Reviews, 2014
Jean-Christophe Lega, Nicole Fabien, Quitterie Reynaud   +2 more
exaly  

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

Lancet Neurology, The, 2007
Merrilee Needham, Mbbs, Fracp
exaly  

Targeting protein homeostasis in sporadic inclusion body myositis

Science Translational Medicine, 2016
Laura Herbelin, Philip M Gallagher, Jeffrey M Statland   +2 more
exaly